Literature DB >> 1281619

Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.

C L Jones1, S Buch, M Post, L McCulloch, E Liu, A A Eddy.   

Abstract

Progressive renal fibrosis is considered to be the final common pathway leading to chronic renal insufficiency. In this study, the authors examined some of the cellular and molecular mechanisms regulating the renal accumulation of extracellular matrix (ECM) proteins using rats with puromycin amino-nucleoside (PAN) nephrosis as an acute model system. Puromycin aminonucleoside rats developed reversible nephrotic syndrome accompanied by an interstitial infiltrate of monocytes. The number of interstitial fibroblasts expressing ST4 antigen did not increase. During the first 4 days, steady-state mRNA levels for all genes examined remained at or below control levels. At 1 week, nephrotic syndrome and interstitial inflammation were established, and a period of renal cell proliferation occurred, identified by increased histone mRNA levels and localized by tritiated thymine autoradiography to tubular epithelial cells and occasional interstitial cells. Transforming growth factor-beta (TGF-beta) steady-state mRNA levels were increased eightfold, but returned to control levels by 3 weeks. At week 1, there was a 10- to 20-fold increase in kidney steady-state mRNA levels for genes encoding interstitial matrix proteins collagen I and fibronectin and basement membrane collagen IV. By in situ hybridization, alpha 1(I) procollagen mRNA was localized to interstitial cells. Immunofluorescence microscopy demonstrated focal accumulation of ECM proteins in the tubulointerstitial compartment at 2 and 3 weeks, but by 6 weeks, kidney immunohistology was normal again. Steady-state mRNA levels for the matrix degrading metalloproteinase stromelysin remained at control values, whereas the levels for interstitial collagenase were normal at week 1 and increased twofold to threefold at 2 and 3 weeks. Steady-state mRNA levels for the tissue inhibitor of metalloproteinases (TIMP) increased fivefold at 1 week and returned to baseline values over the next 2 weeks. The results of this study suggest that tubulointerstitial ECM accumulation occurs in rats with acute PAN nephrosis because of the activation of genes encoding several matrix proteins and inhibition of matrix degradation mediated by TIMP. These events are reversed during the phase of recovery from nephrotic syndrome. Increased mRNA levels for TGF-beta, possibly originating from inflammatory interstitial monocytes, are likely to be one of the mediators of the molecular events observed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281619      PMCID: PMC1886759     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  61 in total

1.  Inhibition of normal rat kidney cell growth by transforming growth factor-beta is mediated by collagen.

Authors:  M A Nugent; M J Newman
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

2.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

Authors:  A B Roberts; M B Sporn; R K Assoian; J M Smith; N S Roche; L M Wakefield; U I Heine; L A Liotta; V Falanga; J H Kehrl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Inflammatory and immunomodulatory roles of TGF-beta.

Authors:  S M Wahl; N McCartney-Francis; S E Mergenhagen
Journal:  Immunol Today       Date:  1989-08

Review 4.  On the use of anti-sense RNA: down-regulation of mRNA encoding a metalloproteinase inhibitor.

Authors:  R Khokha; D T Denhardt
Journal:  Anticancer Res       Date:  1987 Jul-Aug       Impact factor: 2.480

5.  Regulation of mesangial cell growth by polypeptide mitogens. Inhibitory role of transforming growth factor beta.

Authors:  F Jaffer; C Saunders; P Shultz; D Throckmorton; E Weinshell; H E Abboud
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

6.  Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury.

Authors:  J R Diamond; I Pesek; S Ruggieri; M J Karnovsky
Journal:  Am J Physiol       Date:  1989-11

7.  Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis.

Authors:  H Nakatsukasa; P Nagy; R P Evarts; C C Hsia; E Marsden; S S Thorgeirsson
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

8.  Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.

Authors:  T B Connor; A B Roberts; M B Sporn; D Danielpour; L L Dart; R G Michels; S de Bustros; C Enger; H Kato; M Lansing
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

9.  Quantitative indexes of aminonucleoside-induced nephrotic syndrome.

Authors:  T E Nevins; T Gaston; J M Basgen
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

10.  Increased expression of PDGF-B (c-sis) mRNA in rat lung precedes DNA synthesis and tissue repair during chronic hyperoxia.

Authors:  J P Fabisiak; J N Evans; J Kelley
Journal:  Am J Respir Cell Mol Biol       Date:  1989-09       Impact factor: 6.914

View more
  16 in total

1.  Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: evidence for a role for insulin-like growth factor I.

Authors:  R Hirschberg
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.

Authors:  Rudolf Fuchshofer; Sabrina Ullmann; Ludwig F Zeilbeck; Matti Baumann; Benjamin Junglas; Ernst R Tamm
Journal:  Histochem Cell Biol       Date:  2011-08-04       Impact factor: 4.304

3.  Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis.

Authors:  Fanny Wai-Tsing Shek; Robert Christopher Benyon; Fiona Mairi Walker; Peter Raymond McCrudden; Sylvia Lin Foon Pender; Elizabeth Jean Williams; Penelope Ann Johnson; Colin David Johnson; Adrian Calvin Bateman; David Roger Fine; John Peter Iredale
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

4.  Proceedings of the American Society of Pediatric Nephrology 1993 Education Symposium, Washington, D.C., 4 May, 1993.

Authors: 
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

Review 5.  Inflammation and glomerular injury.

Authors:  A Benigni; G Remuzzi
Journal:  Springer Semin Immunopathol       Date:  1994

6.  Plasma TGF-β1, MMP-1 and MMP-3 Levels in Chronic Pancreatitis.

Authors:  K Sri Manjari; Pratibha Nallari; A Vidyasagar; A Jyothy; A Venkateshwari
Journal:  Indian J Clin Biochem       Date:  2011-09-30

7.  [Pathogenesis of interstitial kidney fibrosis. Studies in the rat model of unilateral ureteral obstruction].

Authors:  M Sommer; R Fünfstück
Journal:  Med Klin (Munich)       Date:  1997-10-15

8.  Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells.

Authors:  Thian Kui Tan; Guoping Zheng; Tzu-Ting Hsu; Ying Wang; Vincent W S Lee; Xinrui Tian; Yiping Wang; Qi Cao; Ya Wang; David C H Harris
Journal:  Am J Pathol       Date:  2010-01-14       Impact factor: 4.307

9.  Expression profiles of congenital renal dysplasia reveal new insights into renal development and disease.

Authors:  Sanjay Jain; Adrian A Suarez; John McGuire; Helen Liapis
Journal:  Pediatr Nephrol       Date:  2007-04-21       Impact factor: 3.714

10.  Urinary levels of matrix metalloproteinases and their tissue inhibitors in nephrotic children.

Authors:  Anna M Wasilewska; Walentyna M Zoch-Zwierz
Journal:  Pediatr Nephrol       Date:  2008-07-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.